Has Maryam Guiahi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,721 in general payments to Maryam Guiahi, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maryam Guiahi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maryam Guiahi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maryam Guiahi, MD

Complex Family Planning · Santa Barbara, CANPI 1386805521

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,375 of the $1,721 with a category attached, or 79.9%. Organon accounts for 84.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $1,446 and has fallen 91.3% since, to $126 in 2025.

$1,721in general payments, 2019–2025

Across 15 payments — averaging $114.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organon$1K
Biogen$105
Mayne Pharma Commercial LLC$82
Evofem Biosciences, Inc.$38
Millicent US Inc$19
AbbVie$16
plus $15 from 1 others

$7,759in research payments, 2019–2025

Across 2 payments — averaging $3879.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bayer$8K

What the payments were for

Speaking & faculty fees$1,37580%
Travel & lodging$714%
Food & beverage$27416%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organon	2	$1,446
Biogen	1	$105
Mayne Pharma Commercial LLC	6	$82
Evofem Biosciences, Inc.	2	$38
Millicent US Inc	2	$19
AbbVie	1	$16
Merck	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEXPLANON$1,375

How this compares

Too few complex family planning providers in Californiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$1,550

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other complex family planning in Santa Barbara

Paul BlumenthalStanford$21K
Melissa ChenSacramento$12K
Suji UhmStanford$8K
Anne FlynnSacramento$2K
Heather SweeneyLos Angeles$257
Jaclyn GrentzerRiverside$255
Jayne CaronPalo Alto$206
Jennifer KernsSan Francisco$0
Kate ShawStanford$0

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →